News

Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals have announced results from a randomised, placebo-controlled phase 2 trial sponsored by Northwestern University. The study, which evaluated Nexavar (sorafenib) tablets in

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a drug alert to the healthcare community advising them of the recall of the human papillomavirus (HPV) vaccination

Caraco Pharmaceutical Laboratories has entered into a consent decree with the US Food and Drug Administration regarding the company’s drug manufacturing operations. The decree provides a series of

Welichem Biotech has announced the filing with Health Canada of a clinical trial application for its lead, anti-inflammatory drug WBI-1001. The application is for a 3-month, double blinded

Ablynx under the terms of its collaboration with Wyeth Pharmaceuticals, a division of Wyeth, has reached a second milestone. A milestone payment of $4m has been triggered by

The National Rheumatoid Arthritis Society (NRAS) is urging the National Institute for Clinical Excellence (NICE) to reconsider its recommendation in the Appraisal Consultation Document issued on 1st October,

BioCryst Pharmaceuticals has delivered a written response to the request for proposal (RFP) announced on September 21, 2009 from the US Department of Health & Human Services (HHS)

Sanofi-Aventis has announced that ClikSTAR, a new reusable insulin pen, for administration of the 24-hour insulin analog Lantus (insulin glargine [rDNA] injection) or/and the rapid acting insulin analog

AlphaRx has entered into an exclusive collaboration and licensing agreement with Riso Pharma Tech for the development of ARX606T, an early stage product candidate intended for wound treatment.